Article
Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2
eLife · 2021 · Dongjin Jeong, author Hye Sung Kim, author Hye Young Kim, author Min Jueng Kang, author Hyeryeon Jung, author Yumi Oh, author Donghyun Kim, author Jaemoon Koh, author Sung-Yup Cho, author Yoon Kyung Jeon, author Eun Bong Lee, author Seung Hyo Lee, author Eui-Cheol Shin, author Ho Min Kim, author Eugene C Yi, author Doo Hyun Chung, author ([email protected]) David Wallach, editor Tadatsugu Taniguchi, senior_editor
Key facts
| Title | Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2 |
|---|---|
| First author | Dongjin Jeong, author Hye Sung Kim, author Hye Young Kim, author Min Jueng Kang, author Hyeryeon Jung, author Yumi Oh, author Donghyun Kim, author Jaemoon Koh, author Sung-Yup Cho, author Yoon Kyung Jeon, author Eun Bong Lee, author Seung Hyo Lee, author Eui-Cheol Shin, author Ho Min Kim, author Eugene C Yi, author Doo Hyun Chung, author ([email protected]) David Wallach, editor Tadatsugu Taniguchi, senior_editor |
| Journal | eLife |
| Published | Jul 5, 2021 |
| DOI | 10.7554/eLife.48840 |
| Devices mentioned | K822496 |
| Product codes mentioned | JIT, JJH, KPA, MVU, NJT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1